Preliminary results for combined therapy show improvement in MS symptoms
Combining the estrogen hormone estriol with Copaxone, a drug indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS), may improve symptoms in patients with the disorder, according to preliminary ...
Apr 29, 2014
0
0